In order to obtain this action we must pay 2,00$ right now, Regulus Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Crispina Calsada (Chief Financial Officer), Denis Drygin (Chief Scientific Officer), Joseph P. Hagan (President, Chief Executive Officer & Director) and its address is 10628 SCIENCE CENTER DRIVE SUITE 225, SAN DIEGO, California, 92121, United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 2,03$ moving between 1,96$ and 2,09$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
